A U.N. Committee determined that glyphosate probably does not cause cancer, Reuters says.

A proposed sale to Bayer, antitrust concerns, stockholder value, worries over future use of Roundup in Europe and a failure to be paid for GMO traits by farmers in India and Argentina are major concerns facing executives these days at Monsanto’s headquarters in St. Louis. Unfortunately, few of these situations appear favorable to American farmers who are concerned that the proposed ag chemical company mergers will lead to even higher crop input prices.

RESULTS OF A recently conducted No-Till Farmer survey indicate growers are not happy with the sale of Syngenta to a state-owned Chinese company. While most growers didn’t favor a Monsanto buyout of Syngenta last summer, they’d have preferred that deal.